Search for: "Boehringer Ingelheim GmbH"
Results 21 - 40
of 51
Sorted by Relevance
|
Sort by Date
12 Mar 2015, 11:09 am
Today's the day that many pharmaceutical patent term extension-watchers have been waiting for with feelings of optimism or anxiety: the day on which the Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
4 Feb 2009, 10:01 am
Of course, the skills of a well-trained patent attorney come in very handy in getting this kind of application over the high bar at the EPO.The latter approach is what at least one party took in the recent case of Laboratorios Almirall SA v Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat), the judgment of which was issued last week by His Honour Judge Fysh QC. [read post]
6 Apr 2009, 8:20 am
., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
21 Aug 2015, 11:35 am
[T]he drug's two manufacturers - Eli Lilly and Co. of Indianapolis and German partner Boehringer Ingelheim GmbH - have announced only that a three-year study they conducted showed the drug delayed the time until patients died of cardiovascular disease or suffered a heart attack or stroke. [read post]
5 May 2010, 4:46 am
– Supreme Court of Justice decision on Viagra patent (IPKat) (IP tango) Further developments on double patenting at the EPO – T1423/07 Cyclic Amine derivative/BOEHRINGER INGELHEIM VETMEDICA GmbH (IPKat) (EPLAW) General BIO announces new policy on options for increasing access to medicines in the developing world (Patently BIOtech) BIO2010 Day 1 & 2: Getting Settled & Meetings & Measuring Biotechnology Innovation (Biotech Blog) (Biotech… [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
16 Mar 2015, 9:23 am
., and Boehringer Ingelheim GmbH all have similar medications currently in development. [read post]
25 Aug 2009, 1:30 pm
Boehringer Ingelheim International GmbH v Commissioner of Patents [2001] FCA 647 and Prejay Holdings Ltd v Commissioner of Patents [2003] FCAFC 77 applied. [read post]
9 Dec 2010, 2:49 am
” Specifically, “Boehringer Ingelheim GmbH’s Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
30 Dec 2009, 3:44 am
In this event Panels partially dismiss complaints to the extent that they include additional unrelated respondents, as in Boehringer Ingelheim Pharma GmbH & Co. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
16 Mar 2015, 3:10 am
CJEU rules in telmisartan SPC disputeAfter his own earlier post on the CJEU’s decision in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
9 Dec 2010, 3:53 am
" Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
1 Dec 2009, 9:45 am
Intervet Inc. and Boehringer Ingelheim Vetmedica, Inc. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
